IsoPlexis Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022
2021 revenue increased 66% over prior year period BRANFORD, Conn., March 02, 2022 (GLOBE NEWSWIRE)…
News
Manitoba Harvest to Unveil New Superfood Lineup
Pioneers in Hemp and Natural Foods Will Present ‘THE POWER OF HEMP’ and Introduce New…
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results, Issues 2022 Financial Guidance and Provides Business Update
Worldwide Ocaliva® net sales of $92.4 million and $363.5 million for the fourth quarter and…
Instil Bio to Present at the Cowen 42nd Annual Health Care Conference
DALLAS, March 02, 2022 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage…
Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
Industry veteran brings extensive experience in the development and commercialization of advanced biological therapies, including in the…
COMPASS Pathways to participate in Cowen and Roth investor conferences
LONDON, March 02, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
ALX Oncology Announces First Patient Dosed in ASPEN-06, a Phase 2/3 Study of Evorpacept for the Treatment of Patients with Advanced Gastric or Gastroesophageal Junction Cancer
Phase 2/3 study initiated in collaboration with Eli Lilly and Company SOUTH SAN FRANCISCO, Calif.,…
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
WALTHAM, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
PolyPid Announces 750th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ in Abdominal Surgery
Unblinded Interim Analysis Expected in the Second Quarter of 2022 PETACH TIKVA, Israel, March 02,…
Baudax Bio Announces Seventh Orange Book Listable Patent for ANJESO®
MALVERN, Pa., March 02, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…
Jounce Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
– Continued execution on two proof-of-concept clinical trials for JTX-8064 and Vopratelimab, INNATE and SELECT,…
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2021 Financial Results, and Host Conference Call on March 15, 2022
REHOVOT, Israel, March 02, 2022 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived…
Pluristem CEO Issues Shareholder Update
HAIFA, Israel, March 02, 2022 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI),…
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
WATERTOWN, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage…
HOOKIPA Pharma Announces Pricing of $75.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
NEW YORK and VIENNA, Austria, March 02, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (Nasdaq:…
D2L Expands Collaboration and Community in Brightspace
New features enhance personalization and engagement to help support learners through the pandemic and beyond…
Check Point Software’s Cloud Security Report Reveals Complexity of Managing Multi-Cloud Environment and Skills Shortages
Misconfiguration is the number one cause of cloud-security incidents in 2021. Call for unified security solution…
Travladd Crypto: Promoted NFT Project to Get More Whitelist Sponsors and Partnered with Spywolf Crypto Security Agency
London, United Kingdom–(Newsfile Corp. – March 2, 2022) – Travladd has recently promoted an NFT project…
SUPERVERSE Leads with New Consumer-Oriented Web3 Summit
Dubai, United Arab Emirates–(Newsfile Corp. – March 2, 2022) – SUPERVERSE, a new consumer-oriented web3…
LBank Weekly Listing Report, 28th February 2022
Internet City, Dubai–(Newsfile Corp. – March 2, 2022) – As a world class digital asset…